Chapter/Section Purchase

1 Study Coverage
1.1 Dermatomycoses Drug Product Introduction
1.2 Market by Type
1.2.1 Global Dermatomycoses Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 BB-2603
1.2.3 Clotrimazole
1.2.4 Dapaconazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Dermatomycoses Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatomycoses Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Dermatomycoses Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Dermatomycoses Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dermatomycoses Drug Sales by Region
2.4.1 Global Dermatomycoses Drug Sales by Region (2017-2022)
2.4.2 Global Sales Dermatomycoses Drug by Region (2023-2028)
2.5 Global Dermatomycoses Drug Revenue by Region
2.5.1 Global Dermatomycoses Drug Revenue by Region (2017-2022)
2.5.2 Global Dermatomycoses Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatomycoses Drug Sales by Manufacturers
3.1.1 Global Top Dermatomycoses Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Dermatomycoses Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatomycoses Drug in 2021
3.2 Global Dermatomycoses Drug Revenue by Manufacturers
3.2.1 Global Dermatomycoses Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Dermatomycoses Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dermatomycoses Drug Revenue in 2021
3.3 Global Dermatomycoses Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatomycoses Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatomycoses Drug Sales by Type
4.1.1 Global Dermatomycoses Drug Historical Sales by Type (2017-2022)
4.1.2 Global Dermatomycoses Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Dermatomycoses Drug Sales Market Share by Type (2017-2028)
4.2 Global Dermatomycoses Drug Revenue by Type
4.2.1 Global Dermatomycoses Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Dermatomycoses Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dermatomycoses Drug Revenue Market Share by Type (2017-2028)
4.3 Global Dermatomycoses Drug Price by Type
4.3.1 Global Dermatomycoses Drug Price by Type (2017-2022)
4.3.2 Global Dermatomycoses Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dermatomycoses Drug Sales by Application
5.1.1 Global Dermatomycoses Drug Historical Sales by Application (2017-2022)
5.1.2 Global Dermatomycoses Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Dermatomycoses Drug Sales Market Share by Application (2017-2028)
5.2 Global Dermatomycoses Drug Revenue by Application
5.2.1 Global Dermatomycoses Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Dermatomycoses Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dermatomycoses Drug Revenue Market Share by Application (2017-2028)
5.3 Global Dermatomycoses Drug Price by Application
5.3.1 Global Dermatomycoses Drug Price by Application (2017-2022)
5.3.2 Global Dermatomycoses Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dermatomycoses Drug Market Size by Type
6.1.1 North America Dermatomycoses Drug Sales by Type (2017-2028)
6.1.2 North America Dermatomycoses Drug Revenue by Type (2017-2028)
6.2 North America Dermatomycoses Drug Market Size by Application
6.2.1 North America Dermatomycoses Drug Sales by Application (2017-2028)
6.2.2 North America Dermatomycoses Drug Revenue by Application (2017-2028)
6.3 North America Dermatomycoses Drug Market Size by Country
6.3.1 North America Dermatomycoses Drug Sales by Country (2017-2028)
6.3.2 North America Dermatomycoses Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatomycoses Drug Market Size by Type
7.1.1 Europe Dermatomycoses Drug Sales by Type (2017-2028)
7.1.2 Europe Dermatomycoses Drug Revenue by Type (2017-2028)
7.2 Europe Dermatomycoses Drug Market Size by Application
7.2.1 Europe Dermatomycoses Drug Sales by Application (2017-2028)
7.2.2 Europe Dermatomycoses Drug Revenue by Application (2017-2028)
7.3 Europe Dermatomycoses Drug Market Size by Country
7.3.1 Europe Dermatomycoses Drug Sales by Country (2017-2028)
7.3.2 Europe Dermatomycoses Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatomycoses Drug Market Size by Type
8.1.1 Asia Pacific Dermatomycoses Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Dermatomycoses Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Dermatomycoses Drug Market Size by Application
8.2.1 Asia Pacific Dermatomycoses Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Dermatomycoses Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Dermatomycoses Drug Market Size by Region
8.3.1 Asia Pacific Dermatomycoses Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Dermatomycoses Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatomycoses Drug Market Size by Type
9.1.1 Latin America Dermatomycoses Drug Sales by Type (2017-2028)
9.1.2 Latin America Dermatomycoses Drug Revenue by Type (2017-2028)
9.2 Latin America Dermatomycoses Drug Market Size by Application
9.2.1 Latin America Dermatomycoses Drug Sales by Application (2017-2028)
9.2.2 Latin America Dermatomycoses Drug Revenue by Application (2017-2028)
9.3 Latin America Dermatomycoses Drug Market Size by Country
9.3.1 Latin America Dermatomycoses Drug Sales by Country (2017-2028)
9.3.2 Latin America Dermatomycoses Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dermatomycoses Drug Market Size by Type
10.1.1 Middle East and Africa Dermatomycoses Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dermatomycoses Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Dermatomycoses Drug Market Size by Application
10.2.1 Middle East and Africa Dermatomycoses Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dermatomycoses Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Dermatomycoses Drug Market Size by Country
10.3.1 Middle East and Africa Dermatomycoses Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dermatomycoses Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Anacor Pharmaceuticals Inc
11.1.1 Anacor Pharmaceuticals Inc Corporation Information
11.1.2 Anacor Pharmaceuticals Inc Overview
11.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Anacor Pharmaceuticals Inc Recent Developments
11.2 Biolab Farmaceutica Ltda
11.2.1 Biolab Farmaceutica Ltda Corporation Information
11.2.2 Biolab Farmaceutica Ltda Overview
11.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biolab Farmaceutica Ltda Recent Developments
11.3 Blueberry Therapeutics Ltd
11.3.1 Blueberry Therapeutics Ltd Corporation Information
11.3.2 Blueberry Therapeutics Ltd Overview
11.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Blueberry Therapeutics Ltd Recent Developments
11.4 Daewoong Pharmaceutical Co Ltd
11.4.1 Daewoong Pharmaceutical Co Ltd Corporation Information
11.4.2 Daewoong Pharmaceutical Co Ltd Overview
11.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daewoong Pharmaceutical Co Ltd Recent Developments
11.5 Dermala Inc
11.5.1 Dermala Inc Corporation Information
11.5.2 Dermala Inc Overview
11.5.3 Dermala Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dermala Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dermala Inc Recent Developments
11.6 Helix BioMedix Inc
11.6.1 Helix BioMedix Inc Corporation Information
11.6.2 Helix BioMedix Inc Overview
11.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Helix BioMedix Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Helix BioMedix Inc Recent Developments
11.7 Novan Inc
11.7.1 Novan Inc Corporation Information
11.7.2 Novan Inc Overview
11.7.3 Novan Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novan Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novan Inc Recent Developments
11.8 Sol-Gel Technologies Ltd
11.8.1 Sol-Gel Technologies Ltd Corporation Information
11.8.2 Sol-Gel Technologies Ltd Overview
11.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sol-Gel Technologies Ltd Recent Developments
11.9 TGV-Laboratories
11.9.1 TGV-Laboratories Corporation Information
11.9.2 TGV-Laboratories Overview
11.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 TGV-Laboratories Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 TGV-Laboratories Recent Developments
11.10 Viamet Pharmaceuticals Inc
11.10.1 Viamet Pharmaceuticals Inc Corporation Information
11.10.2 Viamet Pharmaceuticals Inc Overview
11.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Viamet Pharmaceuticals Inc Recent Developments
11.11 Vyome Biosciences Pvt Ltd
11.11.1 Vyome Biosciences Pvt Ltd Corporation Information
11.11.2 Vyome Biosciences Pvt Ltd Overview
11.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vyome Biosciences Pvt Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermatomycoses Drug Industry Chain Analysis
12.2 Dermatomycoses Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatomycoses Drug Production Mode & Process
12.4 Dermatomycoses Drug Sales and Marketing
12.4.1 Dermatomycoses Drug Sales Channels
12.4.2 Dermatomycoses Drug Distributors
12.5 Dermatomycoses Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatomycoses Drug Industry Trends
13.2 Dermatomycoses Drug Market Drivers
13.3 Dermatomycoses Drug Market Challenges
13.4 Dermatomycoses Drug Market Restraints
14 Key Findings in The Global Dermatomycoses Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer